Jennifer K. Simpson
CEO, President & DirectorDr. Jennifer K. Simpson, Ph.D. M.S.N. C.R.N.P. has been the Chief Executive Officer, President and Director of Panbela Therapeutics, Inc. (formerly known as Sun BioPharma, Inc.) since July 15, 2020. She serves as a Lead Independent Director of Eagle Pharmaceuticals, Inc. since March 8, 2024. She Joined Panbela Therapeutics, Inc. (formerly known as Sun BioPharma, Inc.) in July 2020. Dr. Simpson served as Independent Director at LadRx Corporation (formerly known as CytRx Corporation) since July 29, 2021 until July 28, 2025 and served as its Chairperson since July 27, 2022 until July 28, 2025. Dr. Simpson served as the President of Delcath Systems, Inc. since May 2015 to until June 1, 2020 and served as its Chief Executive Officer since May 2015 to until June 1, 2020. Dr. Simpson served as an Interim Co-Chief Executive Officer and Interim Co-President of Delcath Systems, Inc. since September 2013. In September 2014, Dr. Simpson was named Interim President and Chief Executive Officer. Dr. Simpson served as Global Head of Business Operations and Executive Vice President of Delcath Systems, Inc. since April 8, 2013. Dr. Simpson served as an Executive Vice President of Global Marketing at Delcath Systems, Inc. since March 26, 2012 until April 8, 2013. Dr. Simpson joined Delcath in March 2012 and has an extensive background in Pharmaceutical and Oncology Marketing, including responsibility for global product development in the oncology sector. Dr. Simpson served as the Vice President of Global Marketing, Oncology Brand Lead at ImClone Systems, Inc. (a wholly owned subsidiary of Eli Lilly and Company), from May 2011 to March 2012, where she was responsible for all product commercialization activities and launch preparation for one of the late-stage assets. Dr. Simpson served as a Director of Delcath Systems, Inc. since May 2015 to until June 1, 2020. From June 2009 to May 2011, Dr. Simpson served as Vice President of Product Champion and from 2008 to 2009 as the Associate Vice President of Product Champion for ImClone?s product Ramucirumab. From 2006 to 2008, Dr. Simpson served as Product Director, Oncology Therapeutics Marketing at Ortho Biotech (now Janssen Biotech). Dr. Simpson spent over a decade as a hematology/oncology nurse practitioner and educator. Dr. Simpson serves as an Independent Director of Eagle Pharmaceuticals, Inc. since August 28, 2019. Dr. Simpson earned a Ph.D. in Epidemiology from the University of Pittsburgh, an M.S. in Nursing from the University of Rochester and a B.S. in Nursing from the State University of New York at Buffalo.
Positions
- Company NamePanbela Therapeutics, Inc.Stock CodePBLAPositionCEO, President & Director
- Company NameEagle Pharmaceuticals, Inc.Stock CodeEGRXPositionLead Independent DirectorColleagues
- MGMichael GravesCEO & Chairman
- CSChristopher Stanley KrawtschukCFO and Principal Financial & Accounting Officer
- DODaniel O'ConnorExecutive VP, Chief Strategy Officer & Head of Corporate Development
- VRValentin R. CurtSenior Vice President of Clinical Drug Development
- RLRobert L. GlenningIndependent Director
- RARichard A. EdlinIndependent Director
- JKJennifer K. SimpsonLead Independent Director
- SBSteven B. RatoffDirector
